Mark E. Robinson
Impact in
-
- interferon and immune responses
- T-cell and B-cell Immunology
Papers in
-
- Genomics and Chromatin Dynamics 2
- DNA Repair Mechanisms 2
- Co-authors
- Niklas Feldhahn (5 shared papers)Leandro Castellano (2 shared papers)Jakob Loschko (1 shared paper)Mathieu-Benoı̂t Voisin (1 shared paper)Carles Gaston‐Massuet (1 shared paper)Marika Charalambous (1 shared paper)Elizabeth G. Wood (1 shared paper)Féaron C. Cassidy (1 shared paper)
- Journals
- Blood (2 papers)Science Translational Medicine (2 papers)Nature (2 papers)Proceedings of the National Academy of Sciences (2 papers)Nature Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mark E. Robinson
21 papers receiving 541 citations
Peers
Comparison fields: 5 of 66
- Immunology 70
- Hematology 44
- Epidemiology 86
- Cellular and Molecular Neuroscience 40
- Genetics 20
Countries citing papers authored by Mark E. Robinson
This map shows the geographic impact of Mark E. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Robinson more than expected).
Fields of papers citing papers by Mark E. Robinson
This network shows the impact of papers produced by Mark E. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Robinson. The network helps show where Mark E. Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 131 | |
| 2 | 2020 | 72 | |
| 3 | 2024 | 64 | |
| 4 | 2020 | 50 | |
| 5 | 2021 | 49 | |
| 6 | 2019 | 40 | |
| 7 | 2021 | 39 | |
| 8 | 2021 | 24 | |
| 9 | 2020 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2017 | 13 | |
| 12 | 2019 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2026 | 2 | |
| 18 | 2020 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2022 | 1 |
About Mark E. Robinson
Mark E. Robinson is a scholar working on Hematology, Molecular Biology, Genetics, Cancer Research and Cellular and Molecular Neuroscience, having authored 21 papers that have together received 544 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Genomics and Chromatin Dynamics (2 papers), Blood disorders and treatments (2 papers), DNA Repair Mechanisms (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Lymphatic System and Diseases (1 paper) and Axon Guidance and Neuronal Signaling (1 paper). The work is most often cited by research in Immunology (70 citations), Hematology (44 citations), Epidemiology (86 citations), Cellular and Molecular Neuroscience (40 citations) and Genetics (20 citations). Mark E. Robinson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Niklas Feldhahn, Leandro Castellano, Jakob Loschko, Mathieu-Benoı̂t Voisin, Carles Gaston‐Massuet, Marika Charalambous, Elizabeth G. Wood, Féaron C. Cassidy, Federica M. Marelli‐Berg and Valeria Scagliotti. Their work appears in journals such as Blood, Science Translational Medicine, Nature, Proceedings of the National Academy of Sciences and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.